Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board NomineesGlobeNewsWire • 05/12/26
Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and ImmunologyPRNewsWire • 05/12/26
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.The Motley Fool • 05/12/26
Bristol Myers Squibb Touts Pipeline Gains as Shareholders Back Board at Annual MeetingMarketBeat • 05/10/26
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in AdultsBusiness Wire • 05/08/26
6 Pharma Dividend Stocks Yielding Up to 6.44% — and They've Survived Every Market Crash24/7 Wall Street • 05/06/26
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026Business Wire • 05/06/26
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™Business Wire • 05/04/26
Bristol Myers (BMY) Reports Q1 Earnings: What Key Metrics Have to SayZacks Investment Research • 04/30/26
Bristol Myers Squibb (BMY) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 04/30/26
Bristol Myers posts higher-than-expected quarterly profit on blood thinner, cancer salesReuters • 04/30/26